Financial News
Articles published by AstraZeneca
![](https://mms.businesswire.com/media/20211223005099/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211217005407/en/1310318/5/TEZSPIRE_Logo.jpg)
TEZSPIRE (tezepelumab) Approved in the US for Severe Asthma
December 17, 2021
From AstraZeneca
Via Business Wire
![](https://mms.businesswire.com/media/20211216005736/en/484259/5/Logo.jpg)
EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in independent FDA study
December 16, 2021
From AstraZeneca
Via Business Wire
Tickers
AZN
![](https://mms.businesswire.com/media/20211212005048/en/484259/5/Logo.jpg)
![](https://www.acnnewswire.com/images/hp_top.gif)
From AstraZeneca
Via ACN Newswire
![](https://www.acnnewswire.com/images/hp_top.gif)
Inaugural Asia Summit on Global Health opens today
November 24, 2021
From AstraZeneca
Via ACN Newswire
![](https://www.acnnewswire.com/images/hp_top.gif)
Inaugural Asia Summit on Global Health highlights Hong Kong's advantages
November 17, 2021
From AstraZeneca
Via ACN Newswire
![](https://mms.businesswire.com/media/20211209005708/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211208006139/en/930407/5/EVUS_TM_Prom_RGB_FC_Pos.jpg)
![](https://mms.businesswire.com/media/20211203005080/en/484259/5/Logo.jpg)
AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care
December 03, 2021
From AstraZeneca
Via Business Wire
Tickers
AZN
![](https://mms.businesswire.com/media/20211130005457/en/484259/5/Logo.jpg)
LYNPARZA® (olaparib) Granted Priority Review in the US for BRCA-Mutated HER2-Negative High-Risk Early Breast Cancer
November 30, 2021
From AstraZeneca
Via Business Wire
Tickers
AZN
![](https://mms.businesswire.com/media/20211118005506/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211117006015/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211105005227/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211101005708/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211101005061/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211025005799/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211021005771/en/918648/5/BOB_HARPER_0051_VS_R1_Resize.jpg)
![](https://mms.businesswire.com/media/20211020005098/en/484259/5/Logo.jpg)
AstraZeneca Announces Winners and Recognizes Oncology Change Makers in Third Annual Cancer Community Awards
October 20, 2021
From AstraZeneca
Via Business Wire
Tickers
AZN
![](https://mms.businesswire.com/media/20211015005143/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211008005144/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20211005005414/en/484259/5/Logo.jpg)
AZD7442 Request for Emergency Use Authorization for COVID-19 Prophylaxis Filed in US
October 05, 2021
From AstraZeneca
Via Business Wire
Tickers
AZN
![](https://mms.businesswire.com/media/20211004005227/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20210927005211/en/484259/5/Logo.jpg)
AstraZeneca COVID-19 and RSV presentations at IDWeek 2021 will showcase scientific progress in infectious diseases
September 27, 2021
From AstraZeneca
Via Business Wire
Tickers
AZN
![](https://mms.businesswire.com/media/20210924005088/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20210918005025/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20210918005024/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20210918005008/en/484259/5/Logo.jpg)
![](https://mms.businesswire.com/media/20210917005413/en/484259/5/Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.